Resources from the same session
113MO - NATALEE update: Safety and treatment (tx) duration of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2- early breast cancer (EBC)
Presenter: Carlos Barrios
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast